Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

Table 2 Hazard ratios of death from BC, CV disease and other causes by levels of glucose, TG, and TC

	No. of subjects	BC death			CV death			Other death
	No. of subjects	No. of events	HR^a	95 % CI	No. of events	HR^a	95 % CI	No. of events	HR^a	95 % CI
Glucose, mmol/L^b
Continuous log			0.96	0.58, 1.59		2.48	1.24, 4.96		2.09	1.16, 3.76
Quartiles
< 4.50	393	98	1		21	1		45	1
4.50–4.90	413	116	0.98	0.75, 1.29	36	1.27	0.74, 2.19	63	1.12	0.76, 1.64
4.90–5.30	363	96	0.95	0.72, 1.27	41	1.28	0.75, 2.19	50	0.87	0.58, 1.30
≥ 5.30	416	115	0.98	0.74, 1.29	80	1.67	1.02, 2.73	100	1.32	0.92, 1.89
P _trend			0.83			0.03			0.20
TG, mmol/L^c
Continuous log			1.21	0.98, 1.48		1.58	1.17, 2.13		1.32	1.02, 1.71
Quartiles
< 0.70	297	81	1		12	1		24	1
0.70–1.00	491	102	0.77	0.57, 1.04	34	0.91	0.46, 1.77	56	0.96	0.59, 1.57
1.00–1.60	555	132	0.97	0.72, 1.29	52	1.10	0.58, 2.08	95	1.28	0.81, 2.03
≥ 1.60	455	110	1.05	0.76, 1.45	80	1.53	0.81, 2.90	83	1.22	0.75, 1.98
P _trend			0.35			0.01			0.16
TC, mmol/L^d
Continuous log			0.72	0.40, 1.28		2.04	0.83, 5.04		0.67	0.32, 1.42
Quartiles
< 5.20	443	119	1		16	1		38	1
5.20–5.80	403	94	0.87	0.66, 1.14	37	1.52	0.83, 2.76	60	1.18	0.78, 1.79
5.80–6.60	470	102	0.79	0.60, 1.04	40	1.26	0.70, 2.27	75	1.06	0.72, 1.58
≥ 6.60	482	110	0.85	0.64, 1.15	85	1.74	0.99, 3.04	85	0.92	0.61, 1.38
P _trend			0.21			0.08			0.38

^aAdjusted for age at diagnosis, SES (white collar, blue collar, unemployed or unknown), fasting status (fasting, non-fasting, unknown), glucose (continuous), TG (continuous), and TC (continuous)
Not adjusted for ^bglucose, ^cTG, ^dTC

ISSN: 1471-2407